Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Hamlet BioPharma AB
Sponsor

Hamlet BioPharma AB

Sweden S Allhelgonafors., Klinikgatan 32, Lunds Allhelgonafors., 222 42 Lund, Sweden

About the sponsor

Research activity is centered on non-muscle invasive bladder cancer, with attention to patients awaiting transurethral surgery for tumour removal.

  • Bladder cancer
  • Non-muscle invasive disease
  • Preoperative treatment

The clinical focus includes therapeutic options intended for local management of bladder tumours before surgery.

About Specializations

Hamlet BioPharma AB runs clinical trials in conditions such as Bladder transitional cell carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Bladder transitional cell carcinoma

Recruiting

Phase III Randomized Study of Intravesical ALPHA1H as Neoadjuvant Therapy in Patients with Low- to Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA1H
  • Sponsor:Hamlet BioPharma AB

Bladder transitional cell carcinoma

Not recruiting

Study on the Safety and Effectiveness of ALPHA1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA1H
  • Sponsor:Hamlet BioPharma AB

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.